Engineers Gate Manager’s Syndax Pharmaceuticals SNDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.68M | Buy |
179,276
+52,791
| +42% | +$494K | 0.02% | 829 |
|
2025
Q1 | $1.55M | Sell |
126,485
-21,188
| -14% | -$260K | 0.03% | 815 |
|
2024
Q4 | $1.95M | Buy |
147,673
+88,262
| +149% | +$1.17M | 0.03% | 638 |
|
2024
Q3 | $1.14M | Sell |
59,411
-16,429
| -22% | -$316K | 0.02% | 909 |
|
2024
Q2 | $1.56M | Buy |
75,840
+33,353
| +79% | +$685K | 0.04% | 680 |
|
2024
Q1 | $1.01M | Buy |
42,487
+26,247
| +162% | +$625K | 0.03% | 819 |
|
2023
Q4 | $351K | Sell |
16,240
-54,296
| -77% | -$1.17M | 0.01% | 1367 |
|
2023
Q3 | $1.02M | Buy |
70,536
+9,793
| +16% | +$142K | 0.04% | 695 |
|
2023
Q2 | $1.27M | Buy |
60,743
+9,318
| +18% | +$195K | 0.05% | 551 |
|
2023
Q1 | $1.09M | Buy |
+51,425
| New | +$1.09M | 0.05% | 581 |
|
2022
Q2 | – | Sell |
-40,804
| Closed | -$709K | – | 2235 |
|
2022
Q1 | $709K | Buy |
40,804
+17,506
| +75% | +$304K | 0.03% | 875 |
|
2021
Q4 | $510K | Buy |
+23,298
| New | +$510K | 0.02% | 1042 |
|
2021
Q3 | – | Sell |
-16,609
| Closed | -$285K | – | 1952 |
|
2021
Q2 | $285K | Sell |
16,609
-6,759
| -29% | -$116K | 0.02% | 1171 |
|
2021
Q1 | $523K | Buy |
23,368
+5,552
| +31% | +$124K | 0.03% | 967 |
|
2020
Q4 | $396K | Buy |
+17,816
| New | +$396K | 0.02% | 1126 |
|